In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells
about
Stem-cell-based gene therapy for HIV infectionChallenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV ReservoirsStudies of retroviral infection in humanized miceEffective T helper cell responses against retroviruses: are all clonotypes equal?Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infectionNew generation humanized mice for virus research: comparative aspects and future prospectsGene therapy strategies for HIV/AIDS: preclinical modeling in humanized miceUsing animal models to overcome temporal, spatial and combinatorial challenges in HIV persistence researchRectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized miceGenetic Modulation Therapy Through Stem Cell Transplantation for Human Immunodeficiency Virus 1 Infection.Probing the effector and suppressive functions of human T cell subsets using antigen-specific engineered T cell receptorsAPOBEC3G-Augmented Stem Cell Therapy to Modulate HIV Replication: A Computational Study.An AAV vector-mediated gene delivery approach facilitates reconstitution of functional human CD8+ T cells in miceDevelopment of genetically engineered iNKT cells expressing TCRs specific for the M. tuberculosis 38-kDa antigen.Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.Cocaine-mediated impact on HIV infection in humanized BLT mice.Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral PersistenceBLT humanized mice as a small animal model of HIV infection.Ectopic expression of anti-HIV-1 shRNAs protects CD8(+) T cells modified with CD4ζ CAR from HIV-1 infection and alleviates impairment of cell proliferation.In vivo platforms for analysis of HIV persistence and eradication.Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary.HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells.Introduction of exogenous T-cell receptors into human hematopoietic progenitors results in exclusion of endogenous T-cell receptor expression.HIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice.Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors.International AIDS Society global scientific strategy: towards an HIV cure 2016.Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo.Cell therapies for treatment of human immunodeficiency virus infection.Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections.Cell-based gene therapy against HIV.Engineering HIV-Specific Immunity with Chimeric Antigen Receptors.Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy.Targeting type I interferon-mediated activation restores immune function in chronic HIV infection.Humanized mouse as an appropriate model for accelerated global HIV research and vaccine development: current trend.Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model.Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS.Cell and Gene Therapy for HIV Cure.Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1.Novel drugs and treatment strategies for HIV-1.
P2860
Q24607667-C73765D7-DE71-46D0-92E9-3279107A3E9AQ26781511-C1556F7D-0583-4F7F-A0AD-AF416DAD2197Q26849806-765864CA-622F-4458-975F-D989A3A2E27CQ26995251-EB3E6428-4071-42EB-8047-9DACF0E50025Q27005830-EBB28ED0-14E9-4DE8-864D-3F3789573A8AQ27014786-AB0F0E23-896D-4103-87D6-4CD13FE88E42Q27022347-F3DF32FE-AF3A-42E6-9990-9DED39B3EF0EQ28077662-0ACB48DE-AE1F-4914-8561-5988B51F6921Q28488527-FC99F760-B57C-4AFA-9DD2-C7DABED930A6Q33563686-005AF6F0-71E0-4722-8F06-F9E72BB73DF6Q34598553-0C5C8AB2-0622-495C-9769-C39008F5CAC3Q34749384-4C6EC512-926D-4919-8FE8-A2F0BAE6B3A7Q35091621-686B8ADB-9248-4C2D-8D3A-6525EB58BF31Q35595346-F5B6F6E3-0BC6-4795-998C-7B1109F69F79Q35745432-D3653E25-9911-41E5-B029-C8713438D86AQ35754062-3DB5933D-4BFF-4CD5-9ED5-BC7AB60D1537Q35903800-E598E82D-C128-483F-A048-CC412601B2B2Q35998374-FE9277CB-9255-43F6-8659-93E9AD297383Q36390805-F801D363-1370-4BCB-A204-D24826027579Q36515119-D43AF9FF-AC9D-4DBD-92EF-E855678EC174Q36601983-A3CAEE3A-F101-429D-A077-8BFF22B128B2Q36757040-C18E946F-684E-4383-BB86-67665C7ED369Q36883838-9449F926-A5B1-472B-8ED5-A1FE68F12FCFQ37202288-ECB03CBD-1301-45DA-80E5-BB3ED9B4EEC9Q37499526-3494AB67-AD86-4FCD-A9DE-D4E6699D8B91Q37661770-1DA57118-1D65-4B91-B783-D3147B159F55Q38246141-4D726FCD-B5F9-4AF2-8F68-07EA4D2BC23CQ38365989-343968AE-458F-4A0B-B4C2-5389FAF6BCBCQ38366376-25CF0ECD-F695-47B9-BF16-54742E0A6E8CQ38417056-17C0532F-E41A-4CCF-80FC-6460800AD45DQ38529069-A3460AA8-6A10-4EA0-A84C-9AC352D69CA1Q39025469-E2188AE0-EB45-4972-91FB-0EB6C3F4DD76Q39104849-D54F623D-4C83-4104-92CB-32037FCE98FBQ39110897-B3290233-0B3B-4A2F-B952-1C2F7CB765CFQ40548525-09BD03BF-9D23-4774-B1AF-9A27C3B5902FQ40616678-506A0606-0128-4007-A3A2-581B5DAB10E2Q47172279-E9554CB1-0684-4416-BAAF-2E53E135754DQ47236016-DBAC3534-BF01-4FCA-AC6E-A94E76690378Q49309806-21385014-E6E4-4C21-9BAA-0B6702F9F22BQ53119232-551A67A7-C168-44EF-9800-52E81A869535
P2860
In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
In vivo suppression of HIV by ...... eered hematopoietic stem cells
@ast
In vivo suppression of HIV by ...... eered hematopoietic stem cells
@en
In vivo suppression of HIV by ...... eered hematopoietic stem cells
@en-gb
In vivo suppression of HIV by ...... eered hematopoietic stem cells
@nl
type
label
In vivo suppression of HIV by ...... eered hematopoietic stem cells
@ast
In vivo suppression of HIV by ...... eered hematopoietic stem cells
@en
In vivo suppression of HIV by ...... eered hematopoietic stem cells
@en-gb
In vivo suppression of HIV by ...... eered hematopoietic stem cells
@nl
altLabel
In Vivo Suppression of HIV by ...... eered Hematopoietic Stem Cells
@en
prefLabel
In vivo suppression of HIV by ...... eered hematopoietic stem cells
@ast
In vivo suppression of HIV by ...... eered hematopoietic stem cells
@en
In vivo suppression of HIV by ...... eered hematopoietic stem cells
@en-gb
In vivo suppression of HIV by ...... eered hematopoietic stem cells
@nl
P2093
P2860
P3181
P1433
P1476
In vivo suppression of HIV by ...... eered hematopoietic stem cells
@en
P2093
Arumugam Balamurugan
Bernard R Levin
Christian Aguilera-Sandoval
Gregory Bristol
Jerome A Zack
Otto O Yang
Scott G Kitchen
Valerie Rezek
P2860
P304
P3181
P356
10.1371/JOURNAL.PPAT.1002649
P407
P577
2012-01-01T00:00:00Z